We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
HEIP
101
Hudson Edge Investment Partners
New Jersey
$46.8M +$12.3M +245,755 +37%
HCM
102
Highbridge Capital Management
New York
$46.4M -$348K -6,958 -0.8%
BTS
103
BB&T Securities
Virginia
$45.2M +$848K +16,935 +24%
Jacobs Levy Equity Management
104
Jacobs Levy Equity Management
New Jersey
$45.1M -$167K -3,330 -0.4%
NAM
105
NorthCoast Asset Management
Connecticut
$44.6M +$69.9K +1,395 +0.2%
AAMU
106
Amundi Asset Management US
Massachusetts
$44.5M -$77.5K -1,548 -0.2%
Canada Life
107
Canada Life
Manitoba, Canada
$44.4M +$6.92M +138,174 +19%
WCM
108
Wedge Capital Management
North Carolina
$43.8M +$6.62M +132,275 +18%
Ohio Public Employees Retirement System (OPERS)
109
Ohio Public Employees Retirement System (OPERS)
Ohio
$43.2M +$339K +6,778 +0.8%
SGA
110
Sector Gamma AS
Norway
$41.1M +$4.04M +80,600 +11%
Massachusetts Financial Services
111
Massachusetts Financial Services
Massachusetts
$40.9M -$545K -10,890 -1%
U
112
UBS
Switzerland
$40.8M -$5.64M -112,650 -12%
AC
113
Alleghany Corporation
New York
$40.8M +$37.6M +750,000 +1,500%
ACI
114
AMP Capital Investors
Australia
$40.6M -$9.29M -185,556 -19%
AAM
115
Advisors Asset Management
Colorado
$40.4M +$297K +5,939 +0.8%
WBC
116
Westpac Banking Corp
Australia
$40M +$488K +9,736 +1%
DL
117
Delta Lloyd
Netherlands
$39M +$4.45M +88,889 +13%
LCOV
118
London Company of Virginia
Virginia
$38.9M +$38.2M +762,611 New
RIG
119
Roosevelt Investment Group
New York
$38.8M -$12.1M -242,538 -24%
VanEck Associates
120
VanEck Associates
New York
$38.1M +$27.1M +541,846 +265%
TA
121
Teachers Advisors
New York
$38M -$11.9M -238,284 -24%
NFA
122
Nationwide Fund Advisors
Ohio
$37.8M -$5.75M -114,756 -13%
Chevy Chase Trust
123
Chevy Chase Trust
Maryland
$37.6M +$655K +13,077 +2%
PI
124
PGGM Investments
Netherlands
$36.9M -$507K -10,118 -1%
State of Wisconsin Investment Board
125
State of Wisconsin Investment Board
Wisconsin
$36.1M +$6.95M +138,790 +24%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.